EyePoint Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Watertown, Massachusetts, dedicated to developing innovative therapeutics for serious ocular diseases. Utilizing its proprietary micro-insert technology, the company specializes in sustained-release drug delivery systems designed to meet significant unmet medical needs in ophthalmology. With a robust pipeline targeting conditions such as retinal diseases, EyePoint is strategically poised for growth in major markets, including the United States, China, and the United Kingdom, establishing itself as a critical contributor in the advancing field of eye care.
Click "Analyze" to generate stock analysis
EYPT Price Trend and Signals
EYPT Option Volumes & Open Interests (aggregated)
EYPT Put Call Ratios and IV (aggregated)
EYPT Financials
2025-10-22Somewhat Bearishprice_signal
Monthly low detected.
2025-10-16Somewhat Bearishprice_signal
Monthly low detected.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-15Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.